MARKSANS PHARMA LTD.
Financial ratio
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 5.88 | 4.51 | 5.76 | 2.86 | 1.87 |
CEPS(Rs) | 7.00 | 5.66 | 6.71 | 3.60 | 2.52 |
DPS(Rs) | 0.50 | 0.25 | 0.25 | 0.10 | 0.05 |
Book NAV/Share(Rs) | 38.51 | 27.10 | 21.66 | 15.54 | 13.25 |
Tax Rate(%) | 21.42 | 24.52 | 21.06 | 23.17 | 22.88 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 16.64 | 16.71 | 24.40 | 16.95 | 13.21 |
EBIT Margin(%) | 17.00 | 16.53 | 22.28 | 14.63 | 11.40 |
Pre Tax Margin(%) | 16.56 | 15.98 | 21.71 | 13.86 | 10.43 |
PAT Margin (%) | 13.01 | 12.06 | 17.14 | 10.65 | 8.04 |
Cash Profit Margin (%) | 15.55 | 14.95 | 19.74 | 13.00 | 10.32 |
Performance Ratios | |||||
ROA(%) | 13.66 | 12.94 | 22.40 | 14.17 | 10.49 |
ROE(%) | 18.59 | 18.72 | 31.33 | 20.49 | 15.88 |
ROCE(%) | 22.89 | 23.82 | 39.76 | 25.57 | 18.51 |
Asset Turnover(x) | 1.05 | 1.07 | 1.31 | 1.33 | 1.30 |
Sales/Fixed Asset(x) | 2.62 | 2.42 | 2.49 | 2.12 | 2.00 |
Working Capital/Sales(x) | 1.53 | 1.83 | 2.30 | 3.11 | 3.35 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.38 | 0.41 | 0.40 | 0.47 | 0.50 |
Receivable days | 72.63 | 78.56 | 67.57 | 67.57 | 64.51 |
Inventory Days | 81.36 | 97.65 | 84.73 | 86.10 | 93.32 |
Payable days | 85.31 | 93.88 | 85.57 | 69.55 | 67.39 |
Valuation Parameters | |||||
PER(x) | 11.99 | 10.10 | 8.67 | 4.86 | 13.30 |
PCE(x) | 10.07 | 8.05 | 7.44 | 3.86 | 9.85 |
Price/Book(x) | 1.83 | 1.68 | 2.31 | 0.89 | 1.87 |
Yield(%) | 0.71 | 0.55 | 0.50 | 0.72 | 0.20 |
EV/Net Sales(x) | 1.36 | 1.04 | 1.35 | 0.44 | 1.08 |
EV/Core EBITDA(x) | 6.32 | 5.18 | 5.35 | 2.57 | 7.92 |
EV/EBIT(x) | 7.27 | 6.08 | 5.97 | 2.98 | 9.51 |
EV/CE(x) | 1.13 | 0.94 | 1.51 | 0.55 | 1.35 |
M Cap / Sales | 1.72 | 1.25 | 1.49 | 0.50 | 1.02 |
Growth Ratio | |||||
Net Sales Growth(%) | 24.23 | 8.33 | 21.33 | 13.41 | 9.57 |
Core EBITDA Growth(%) | 32.55 | -13.16 | 79.82 | 40.81 | 57.46 |
EBIT Growth(%) | 35.48 | -17.47 | 86.93 | 45.59 | 89.88 |
PAT Growth(%) | 42.02 | -21.68 | 97.54 | 50.12 | 124.68 |
EPS Growth(%) | 30.32 | -21.77 | 101.63 | 53.05 | 132.11 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.02 | 0.04 | 0.02 | 0.03 | 0.18 |
Current Ratio(x) | 4.65 | 3.22 | 3.02 | 2.59 | 2.28 |
Quick Ratio(x) | 3.33 | 2.11 | 1.67 | 1.54 | 1.02 |
Interest Cover(x) | 37.99 | 30.31 | 38.84 | 18.97 | 11.80 |
Total Debt/Mcap(x) | 0.01 | 0.02 | 0.01 | 0.03 | 0.10 |